Nuclear factor-κB regulates cyclooxyoenase-2 expression and cell proliferation in human gastric cancer cells

Laboratory Investigation

Volumn 81, Issue 3, 2001, Pages 349-360

  Joo Weon Lim, ^a   Kim, H ^a   Kyung Hwan Kim, ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ANTISENSE OLIGODEOXYNUCLEOTIDE; CYCLOOXYGENASE 2; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2; PROTEIN P50; THROMBOXANE B2; THYMIDINE; ANTISENSE OLIGONUCLEOTIDE; CYCLOOXYGENASE 2 INHIBITOR; DNA BINDING PROTEIN; ISOENZYME; MEMBRANE PROTEIN; MESSENGER RNA; N-(2-CYCLOHEXYLOXY-4-NITROPHENYL)METHANESULFONAMIDE; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; NITROBENZENE DERIVATIVE; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PTGS2 PROTEIN, HUMAN; SULFONAMIDE;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; PRIORITY JOURNAL; STOMACH CANCER; ADENOCARCINOMA; CELL CULTURE; CELL DIVISION; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTAGENESIS; PHYSIOLOGY; STOMACH TUMOR;

6-KETOPROSTAGLANDIN F1 ALPHA; ADENOCARCINOMA; CELL DIVISION; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; I-KAPPA B PROTEINS; ISOENZYMES; MEMBRANE PROTEINS; MUTAGENESIS; NF-KAPPA B; NITROBENZENES; OLIGONUCLEOTIDES, ANTISENSE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER; STOMACH NEOPLASMS; SULFONAMIDES; THROMBOXANE B2; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035086794     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780243     Document Type: Article

References (79)

1. TGF-β1 inhibits NF-κB/Rel activity inducing apoptosis of B cells: Transcriptional activation of lκBα
2. NF-κB: Ten years after
3. Function and activation of NF-κB in the immune system
4. Nuclear factor-κB, a pivotal transcription factor in chronic inflammatory diseases
5. Cyclooxygenase-2 expression in human adenocarcinoma cell line HT29
6. The I kappa B proteins: Multifunctional regulators of Rel/NF-kappa B transcription factors
7. Cell cycle effects of prostaglandins A1, A2, and D2 in human and murine melanoma cells in culture
8. Pentoxifylline inhibits HIV-1 LTR-driven gene expression by blocking NF-κB action
9. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis
10. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
11. Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding
12. Control of lκBα proteolysis by site-specific, signal-induced phosphorylation
13. Effect of β-carotene supplementation on the activity of ornithine decarboxylase (ODC) in stomach mucosa of patients with atrophic gastritis
14. lκBα overexpression in human breast carcinoma MCF7 cells inhibits nuclear factor-κB activation but not tumor necrosis factor-α-induced apoptosis
15. Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells
16. 2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells
17. Single-step method of RNA isolation by acid guanidine isothiocyanate-phenol-chloroform extraction
18. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers
19. Helicobacter pylori as a pathogen and carcinogen
20. Therapeutic applications of oligonucleotides
21. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells
22. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: Independence from COX-2 protein expression
23. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer
24. Role of NF-κB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2
25. The association of Helicobacter pylori and gastric cancer and preneoplastic gastric lesions in Chiapas, Mexico
26. Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines
27. Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity
28. Non-small cell lung cancer cyclooxygenase activity and proliferation are inhibited by non-steroidal anti-inflammatory drugs
29. Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells: Evidence for growth suppression by inhibiting COX-2 expression
30. Antisense inhibition of the p65 subunit of NF-κB blocks tumorigenicity and causes tumor regression
31. Human cyclooxygenase-2 cDNA
32. Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor κB super-repressor in human intestinal epithelial cells
33. Helicobacter pylori infection activates NF-κB in gastric epithelial cells
34. Clinical presentation of peptic ulcer in the elderly
35. Effects of mannitol and dimethylthiourea on Helicobacter pylori-induced IL-8 production in gastric epithelial cells
36. Inhibition of lipid peroxidation, NF-κB activation and IL-8 production by rebamipide in Helicobacter pylori-stimulated gastric epithelial cells
37. Ablation of transplanted HTLV-l Tax-transformed tumors in mice by antisense inhibition of NF-κB
38. Lipopolysaccharide increases cyclooxygenase-2 expression in a colon carcinoma cell line through nuclear factor-κB activation
39. Cationic liposomes improve stability and intracellular delivery of antisense oligonucleotides into CaSki cells
40. Promoter analysis of the gene encoding the lκB/MAD-3 inhibitor of NF-κB: Positive regulation by members of the Rel/NF-κB family
41. Inhibitors of both nuclear factor-κB and activator protein-1 activation block the neoplastic transformation response
42. Regulation of the NF-κB/rel transcription factor and lκB inhibitor system
43. Helicobacter pylori, gastric cancer and gastric epithelial kinetics: A review
44. Role of prostaglandin H synthase-2-mediated conversion of arachidonic acid in controlling 3T6 fibroblast growth
45. 2 in fetal rat osteoblasts: Role of protein kinase A signaling pathway
46. Current concepts in antisense drug design
47. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: Growth inhibition by nonsteroidal anti-inflammatory drugs
48. 2 regulate differently IL-12 production in human intestinal lamina propria mononuclear cells
49. The carcinogenic effect of Helicobacter pylori on the gastric epithelial cell
50. Molecular structure of the human cytoplasmic β-actin gene: Interspecies homology of sequences in the introns
51. Enhancement of cell proliferation and prostaglandin biosynthesis by 1,8-dihydroxyanthraquinone in the rat large intestine
52. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues
53. Infection, immunity, and cancer
54. Oxidation and genotoxicity of fecapentaene-12 are potentiated by prostaglandin H synthase
55. Expression of cyclooxygenase-2 in human gastric carcinoma
56. Effects of NSAIDs on proliferation of gastric cancer cells in vitro: Possible implication of cyclooxygenase-2 in cancer development
57. Involvement of cyclooxygenase-2 in proliferation and morphogenesis induced by transforming growth factor alpha in gastric epithelial cells
58. Mediation of inflammation by COX-2
59. Pharmacological and biochemical demonstration of the role of cyclooxygenase-2 in inflammation and pain
60. Tumorigenic conversion of p53-deficient colon epithelial cells by an activated K-ras gene
61. + Helicobacter pylori strains induce enhanced activation of transcription factor NF-κB in gastric epithelial cells
62. A selective cyclooxygenase-2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells
63. Eicosanoid production by the human gastric cancer cell line AGS and its relation to cell growth
64. Structure, regulation, and function of NF-κB
65. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer
66. The inhibitory effects of transforming growth factor β1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-κB/Ral expression
67. Autoregulation of the NF-κB transactivator Rel A (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs
68. NF-kappa B: A lesion in family value
69. 2 in human prostatic carcinoma cells
70. Phosphorylation of human Icon serines 32 and 36 controls lκBα proteolysis and NF-κB activation in response to diverse stimuli
71. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
72. Prostaglandin endoperoxide synthase: Why two isoforms?
73. Inhibition of NF-κB/Rel induces apoptosis of murine B cells
74. The NF-κB/Rel and lκB gene families: Mediators of immune response and inflammation
75. 2 production by interleukin-1 beta in arterial smooth muscle cells derived from patients with moyamoya disease
76. Transcriptional roles of nuclear factor κB and nuclear factor-interleukin-6 in the tumor necrosis factor α-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells
77. NF-κB inactivation converts a hepatocyte cell line TNF-α response from proliferation to apoptosis
78. Cyclooxygenase-2 expression in human esophageal carcinoma